Oleo Bone


Nicotinamide Adenine Dinucleotide (NAD) IV infusion has gained popularity in wellness and anti-aging circles over the past years. The infusion delivers the coenzyme directly into the bloodstream, bypassing the digestive system, which may improve its bioavailability. Let’s delve deeper into some of the purported benefits:

  1. Enhanced Cellular Function and Energy: At the cellular level, NAD plays a critical role in mitochondrial function, which is the powerhouse of the cell. NAD helps cells convert food into energy. A decline in NAD levels is associated with aging and various diseases. By increasing NAD levels, cells may function more efficiently, and the body might experience increased vitality.
  2. Improved Cognitive Clarity: Preliminary studies have suggested that NAD can enhance brain function, potentially improving focus, clarity, and memory. As NAD is vital for energy production in neurons, maintaining optimal levels might protect against neurodegenerative conditions.
  3. Reduction in Fatigue: Many patients report an increase in energy and a decrease in chronic fatigue after undergoing NAD IV therapy. This is likely linked to the coenzyme’s role in cellular energy production.
  4. Support in Addiction Recovery: Some clinics have introduced NAD IV therapy as a part of addiction recovery programs, suggesting it can reduce withdrawal symptoms and cravings. The theory is that replenishing the body’s NAD can help restore brain function and neurotransmitter imbalances that often accompany addiction.
  5. Anti-aging Benefits: Preliminary research on animals indicates that boosting NAD levels might slow the aging process by improving mitochondrial function and activating proteins called sirtuins that are involved in cellular health and longevity.


Rajman, L., Chwalek, K., & Sinclair, D. A. (2018). Therapeutic potential of NAD-boosting molecules: The in vivo evidence. Cell Metabolism, 27(3), 529-547.

Mouchiroud, L., Houtkooper, R. H., & Auwerx, J. (2013). NAD⁺ metabolism: A therapeutic target for age-related metabolic disease. Critical Reviews in Biochemistry and Molecular Biology, 48(4), 397-408.